NOTOCORD signed major agreements in the USA
20 Dec 2011

2011 was a successful year for NOTOCORD in the USA !

We have signed a major agreement with one of the top 5 pharmaceutical companies to adopt NOTOCORD’s state-of-the-art software technology in the lines of Drug Discovery and Safety Pharmacology studies. US Army also elected NOTOCORD-hem as its favorite acquisition and analysis software platform.

Many other major and prestigious accounts are already lined-up for 2012 in the US, Asia and Europe.

This is the obvious result of 20+ years of experience capitalized in software development dedicated to drug discovery, safety pharmacology and toxicology studies. Keeping the focus on our core business and competencies (software) we also continuously monitor and integrate new technologies in both software and hardware fields.

Our goal is to offer the widest choice to scientist and guarantee an up-to-date global solution.

As an example, with a dedicated analog/digital interface specifically designed and built to eliminate signal crosstalk and interference, which drastically reduce noise and increase reliability, we are now leading the market in the acquisition and analysis of telemetry signals from ITS/Königsberg Instruments implants.

From the pattern recognition ECG analysis, to the recently developed intra-thoracic pressure analyzer, NOTOCORD-hem provides all the necessary tools for advanced data analysis and reporting in the shortest time.

Ask your sales representative for more information about our latest NOTOCORD-hem 4.3 for Windows 7 (32 & 64 bit); let us show you why many customers prefer NOTOCORD-hem as software of choice for their telemetry studies.